Particle.news
Download on the App Store

Gut Bacteria That Make Serotonin Restore Motility in Mice, Point to IBS Research Path

A Cell Reports study from the University of Gothenburg identifies two human commensals that synthesize bioactive serotonin, offering a preclinical rationale for microbiome therapies.

Overview

  • Limosilactobacillus mucosae and Ligilactobacillus ruminis were identified as human gut microbes that produce biologically active serotonin.
  • Serotonin synthesis arose via decarboxylation of 5‑hydroxytryptophan and appeared to require cooperation between the two species, as monocultures did not produce serotonin in vitro.
  • In germ‑free mice with serotonin deficiency, co‑colonization elevated gut serotonin, increased colonic nerve‑cell density, and normalized intestinal transit time, with effects confined locally rather than in serum.
  • In a human cohort, individuals with IBS showed lower stool abundance of L. mucosae than controls, while overall fecal and serum serotonin levels did not differ between groups.
  • The peer‑reviewed findings expand prior observations that microbiota influence host serotonin by demonstrating direct microbial production, though mechanisms, safety, and clinical efficacy in humans remain unproven.